JP2019513722A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513722A5
JP2019513722A5 JP2018551960A JP2018551960A JP2019513722A5 JP 2019513722 A5 JP2019513722 A5 JP 2019513722A5 JP 2018551960 A JP2018551960 A JP 2018551960A JP 2018551960 A JP2018551960 A JP 2018551960A JP 2019513722 A5 JP2019513722 A5 JP 2019513722A5
Authority
JP
Japan
Prior art keywords
pertactin
subject
composition
medicament
bordetella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018551960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513722A (ja
JP6993984B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/057468 external-priority patent/WO2017167834A1/en
Publication of JP2019513722A publication Critical patent/JP2019513722A/ja
Publication of JP2019513722A5 publication Critical patent/JP2019513722A5/ja
Application granted granted Critical
Publication of JP6993984B2 publication Critical patent/JP6993984B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018551960A 2016-03-29 2017-03-29 変異ボルデテラ菌株および使用方法 Active JP6993984B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662314843P 2016-03-29 2016-03-29
US62/314,843 2016-03-29
PCT/EP2017/057468 WO2017167834A1 (en) 2016-03-29 2017-03-29 Mutant bordetella strains and methods for use

Publications (3)

Publication Number Publication Date
JP2019513722A JP2019513722A (ja) 2019-05-30
JP2019513722A5 true JP2019513722A5 (cg-RX-API-DMAC7.html) 2020-04-02
JP6993984B2 JP6993984B2 (ja) 2022-02-03

Family

ID=58488973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018551960A Active JP6993984B2 (ja) 2016-03-29 2017-03-29 変異ボルデテラ菌株および使用方法

Country Status (10)

Country Link
US (4) US10682377B2 (cg-RX-API-DMAC7.html)
EP (2) EP3436034B1 (cg-RX-API-DMAC7.html)
JP (1) JP6993984B2 (cg-RX-API-DMAC7.html)
CN (2) CN109069535B (cg-RX-API-DMAC7.html)
AU (2) AU2017242541B2 (cg-RX-API-DMAC7.html)
DK (1) DK3436034T3 (cg-RX-API-DMAC7.html)
ES (1) ES3027194T3 (cg-RX-API-DMAC7.html)
FI (1) FI3436034T3 (cg-RX-API-DMAC7.html)
SG (1) SG11201807783UA (cg-RX-API-DMAC7.html)
WO (1) WO2017167834A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2821830T3 (es) 2006-03-10 2021-04-27 Pasteur Institut Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina
DK2424564T3 (en) 2009-04-28 2015-04-27 Inserm Inst Nat De La Santé Et De La Rech Médicale A vaccine for the prevention or treatment of a respiratory pathology allergendrevet
WO2017167834A1 (en) * 2016-03-29 2017-10-05 Institut Pasteur De Lille Mutant bordetella strains and methods for use
CN111278456B (zh) 2017-10-18 2024-08-09 里尔巴斯德研究所 表达血清3型菌毛的鲍特菌属菌株
EP4196155A4 (en) 2020-08-14 2025-03-19 Iliad Biotechnologies, LLC Lyophilized live bordetella vaccines
EP4247397A4 (en) 2020-11-17 2024-11-06 Iliad Biotechnologies, LLC TREATMENT AND PREVENTION OF NEUROPATHOLOGY ASSOCIATED WITH NEURODEGENERATIVE DISEASES
CA3261556A1 (en) 2022-07-22 2024-01-25 Institut National de la Santé et de la Recherche Médicale USE OF BORDETELLA STRAINS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
WO2025257397A1 (en) 2024-06-14 2025-12-18 Institut National de la Santé et de la Recherche Médicale Live attenuated bordetella vaccines capable of producing and secreting heterologous antigens

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (fr) 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
DE69511392T2 (de) * 1994-04-28 2000-03-23 Takeda Chemical Industries, Ltd. Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
AU2004229527B2 (en) 2003-04-11 2009-08-20 Medimmune, Llc Methods of preventing or treating respiratory conditions
ES2821830T3 (es) 2006-03-10 2021-04-27 Pasteur Institut Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina
JP2010508860A (ja) 2006-11-15 2010-03-25 フォリア バイオテック インコーポレイテッド パパイヤモザイクウイルスに基づくインフルエンザ用ワクチン
WO2008118592A2 (en) 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
AU2008266910A1 (en) 2007-06-18 2008-12-24 Hemispherx Biopharma, Inc. Early intervention of viral infections with immune activators
DK2424564T3 (en) * 2009-04-28 2015-04-27 Inserm Inst Nat De La Santé Et De La Rech Médicale A vaccine for the prevention or treatment of a respiratory pathology allergendrevet
WO2010146414A1 (en) 2009-06-15 2010-12-23 National University Of Singapore Influenza vaccine, composition, and methods of use
EP2773371B1 (en) 2011-11-02 2020-01-01 National University of Singapore Effect of an attenuated bordetella strain against allergic disease
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
WO2017167834A1 (en) * 2016-03-29 2017-10-05 Institut Pasteur De Lille Mutant bordetella strains and methods for use

Similar Documents

Publication Publication Date Title
JP2019513722A5 (cg-RX-API-DMAC7.html)
US20230381224A1 (en) Mutant Bordetella Strains and Methods of Use
US12403188B2 (en) Bordetella strains expressing serotype 3 fimbriae
JP2025160294A (ja) 結核の感染リスクがある人に対する予防剤として、又は感染した結核患者を治療するための二次薬として使用する組成物
KR102040665B1 (ko) 약독화된 폐렴구균 균주를 포함하는 약제학적 조성물 및 이의 용도
CN106794201A (zh) 包含新型温度敏感性分枝杆菌菌株的对分枝杆菌感染症的疫苗组合物
Preston et al. Mouse or man? Which are pertussis vaccines to protect?
CN116574659A (zh) 一株可缓解类风湿性关节炎的长双歧杆菌婴儿亚种及其应用
CA3018126C (en) Mutant bordetella strains and methods of use
Ismael et al. Development of a Second-Generation Vaccine against Mycoplasmosis: Preparation of a Fraction Candidate from Mycoplasma bovis and Its Evaluation as a Vaccine Department of Animal Medicine, Faculty of Veterinary Medicine, Department of Medical Microbiolog
HK1262896A1 (en) Mutant bordetella strains and methods for use
HK1262896B (zh) 突变型博德特氏菌属菌株及其使用方法
Munir et al. Generation of Protective Antibodies in Mice via Inactivated Whole-Cell Vaccine Targeting Multidrug-Resistant Escherichia coli
CN116355827A (zh) 一种治疗结核病的重组卡介苗药物及其应用
CN119931911A (zh) 一种重组rMS::MPT64及其应用
Goel Interleukin-6 Contributes To Immunity Against Bordetella Pertussis.
Chakraborty et al. Throat Isolates of β-haemolytic Streptococci, from Rural Bengal Showing Reduced Susceptibility to Many Antibiotics